- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05773690
Home-based Training in Obese Individuals (FITOB)
April 29, 2025 updated by: Istituto Auxologico Italiano
Effects of a Home-based Quality of Movement Protocol on Functional Movement, Postural Control and Muscular Strength in Obese Subjects
Generally, the enhancement of physical fitness depends on the optimal modulation of different physiological, technical or psychological stimuli and within the factors the would contribute to a decrease performance level, obesity is one of them.
In this context, ample evidence shows that obesity is associated with an augmented cardio-metabolic risk, lowered postural control, functional performance and strength-related variables.
International guidelines suggests to counteract obesity to respect a minimum dosage of 150 min a week of physical activity at moderate intensity performed with resistance training exercises with a frequency of 2-3 days/week.
However, in the aforementioned guidelines there is a little consideration for what concern the quality of motor execution (i.e., "how" an individual performs each movement pattern).
In addition, the available literature demonstrates the effectiveness of a "movement-quality" training intervention on fitness parameters and postural control, compared to a mere conventional exercise, in normal-weight individuals .
In account to this, the purpose is to evaluate whether a quality of movement protocol would be more effective than a traditional strength training exercise in improving postural control and fitness parameters in subjects with obesity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
96
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy, 20145
- Istituto Auxologico Italiano IRCCS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- physical activity frequency at least 1 days per week
- BMI index more than 30 kg/m2
- informed consent signature
Exclusion Criteria:
- aged more than 70 years
- patients with knee pain (Visual Analogue Scale > 7 a.u.)
- history of hip or knee replacement
- severe hip or knee osteoarthrosis
- cardiac or neurological condition contraindicating physical activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Movement Quality group
movement quality training based on mobility, stability and motor control exercises
|
6-week-home-based training protocols designed to improve general fitness levels and postural control performed in a circuit-training mode (time of work per set 30 s, time of rest between each exercise 15 s, time of rest between sets 2 min, total volume 3 sets) for a duration of 45 min with a frequency of 3 days per week while performing mobility, stability and motor control exercises.
|
|
Experimental: Conventional resistance training group
traditional strength training exercises
|
6-week-home-based training protocols designed to improve general fitness levels and postural control performed in a circuit-training mode (time of work per set 30 s, time of rest between each exercise 15 s, time of rest between sets 2 min, total volume 3 sets) for a duration of 45 min with a frequency of 3 days per week while performing traditional strength training exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline functional performance at six weeks
Time Frame: Up to six weeks
|
Functional performance using the Functional Movement Screen protocol in arbitrary units with a 0-12 point scale in which higher scores mean a better outcome
|
Up to six weeks
|
|
Change from baseline body balance at six weeks
Time Frame: Up to six weeks
|
Body stability using the modified version of the Balance Error Scoring System protocol in arbitrary units with a 0-30 point scale in which lower scores mean a better outcome
|
Up to six weeks
|
|
Change from baseline upper-body muscular strength at six weeks
Time Frame: Up to six weeks
|
Maximal isometric grip strength in kilograms using the handgrip dynamometer
|
Up to six weeks
|
|
Change from baseline lower-body muscular strength at six weeks
Time Frame: Up to six weeks
|
Amount of time in seconds during a chair raise using the Five Repetition Sit-To-Stand protocol
|
Up to six weeks
|
|
Change from baseline breathing pattern at six weeks
Time Frame: Up to six weeks
|
Breathing pattern performance using the Total Faulty Breathing Scale protocol in arbitrary units with a 0-12 point scale in which lower scores mean a better outcome
|
Up to six weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline weight at six weeks
Time Frame: Up to six weeks
|
Body weight using a calibrated weight scale in kilograms
|
Up to six weeks
|
|
Change from baseline height at six weeks
Time Frame: Up to six weeks
|
Body height using a calibrated stadiometer in meters
|
Up to six weeks
|
|
Change from baseline waist circumference at six weeks
Time Frame: Up to six weeks
|
Waist circumference using a 200 centimeters tape measure in centimeters
|
Up to six weeks
|
|
Change from baseline fat mass at six weeks
Time Frame: Up to six weeks
|
Fat mass percentage measurement using a bioelectric impedance analysis
|
Up to six weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Luca Cavaggioni, Istituto Auxologico Italiano IRCCS
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
February 22, 2023
First Submitted That Met QC Criteria
March 6, 2023
First Posted (Actual)
March 17, 2023
Study Record Updates
Last Update Posted (Actual)
May 1, 2025
Last Update Submitted That Met QC Criteria
April 29, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 43C001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Movement quality
-
University of RochesterMayo Clinic; United Therapeutics; University of Vermont Medical CenterRecruitingPulmonary Arterial Hypertension PAHUnited States
-
Hasselt UniversityRevalidatie & MS Centrum Overpelt; National MS Center MelsbroekCompletedMultiple Sclerosis | Cerebral LesionBelgium
-
Cairo UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer... and other conditionsUnited States
-
Johns Hopkins UniversityRecruitingScoliosis | Scoliosis Idiopathic | Scoliosis; Adolescence | Scoliosis Idiopathic Adolescent TreatmentUnited States
-
University of AlbertaCross Cancer InstituteCompletedLymphedema | Breast NeoplasmCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Lung Carcinoma | Esophageal Carcinoma | Malignant Head and Neck NeoplasmUnited States
-
Chueh-Ho LinNational Yang Ming UniversityCompletedStroke | Cardiovascular Disease | Brain Injury | Cerebrovascular AccidentTaiwan
-
Federal University of Health Science of Porto AlegreCompletedRotator Cuff Injuries | Shoulder PainBrazil